Article info

Download PDFPDF
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

Authors

  1. Correspondence to Professor Gabriele Valentini, Department of Precision Medicine, Section of Rheumatology, University of Campania Luigi Vanvitelli, Naples 80131, Italy; gabriele.valentini{at}unicampania.it
View Full Text

Citation

Valentini G, Huscher D, Riccardi A, et al
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

Publication history

  • Received April 4, 2019
  • Revised July 12, 2019
  • Accepted July 31, 2019
  • First published August 7, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.